Fusion of antigen to a dendritic cell targeting chemokine combined with adjuvant yields a malaria DNA vaccine with enhanced protective capabilities.
Although sterilizing immunity to malaria can be elicited by irradiated sporozoite vaccination, no clinically practical subunit vaccine has been shown to be capable of preventing the approximately 600,000 annual deaths attributed to this infection. DNA vaccines offer several potential advantages for...
Main Authors: | Kun Luo, Hong Zhang, Fidel Zavala, Arya Biragyn, Diego A Espinosa, Richard B Markham |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3943962?pdf=render |
Similar Items
-
A chemokine-fusion vaccine targeting immature dendritic cells elicits elevated antibody responses to malaria sporozoites in infant macaques
by: Kun Luo, et al.
Published: (2021-01-01) -
Chemokines as Cancer Vaccine Adjuvants
by: Agne Petrosiute, et al.
Published: (2013-10-01) -
Development of adjuvanted multi-antigen liver-stage malaria vaccines
by: Halbroth, Benedict René
Published: (2016) -
Membrane-anchored chemokine fusion proteins as adjuvants for tumor therapy
by: Münchmeier, Jan Niklas
Published: (2012) -
Design and assessment of TRAP-CSP fusion antigens as effective malaria vaccines.
by: Chafen Lu, et al.
Published: (2020-01-01)